DK0859630T3 - Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer - Google Patents

Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer

Info

Publication number: DK0859630T3
Authority: DK; Denmark
Prior art keywords: combination; thermozolomide; treatment; advanced cancer; alpha ifn
Prior art date: 1995-10-04

Application number

DK96935971T

Other languages

Danish (da)

English (en)

Inventor

H Dugan Margaret

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-04

Filing date

1996-10-01

Publication date

2003-03-24

1996-10-01 Application filed by Schering Corp filed Critical Schering Corp

2003-03-24 Application granted granted Critical

2003-03-24 Publication of DK0859630T3 publication Critical patent/DK0859630T3/da

Links

201000011510 cancer Diseases 0.000 title abstract 2
102000006992 Interferon-alpha Human genes 0.000 abstract 1
108010047761 Interferon-alpha Proteins 0.000 abstract 1
BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 abstract 1
229960004964 temozolomide Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK96935971T 1995-10-04 1996-10-01 Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer DK0859630T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US623395P	1995-10-04	1995-10-04
US62541096A	1996-03-27	1996-03-27
PCT/US1996/015413 WO1997012630A1 (en)	1995-10-04	1996-10-01	Combination of temozolomide and alpha-ifn for the treatment of advanced cancer

Publications (1)

Publication Number	Publication Date
DK0859630T3 true DK0859630T3 (da)	2003-03-24

Family

ID=26675350

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96935971T DK0859630T3 (da)	1995-10-04	1996-10-01	Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer

Country Status (10)

Country	Link
EP (1)	EP0859630B1 (de)
JP (2)	JP4156028B2 (de)
AT (1)	ATE229343T1 (de)
AU (1)	AU719074B2 (de)
CA (1)	CA2233544A1 (de)
DE (1)	DE69625373T2 (de)
DK (1)	DK0859630T3 (de)
ES (1)	ES2183977T3 (de)
PT (1)	PT859630E (de)
WO (1)	WO1997012630A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ536302A (en) *	1999-03-30	2006-05-26	Schering Corp	Cancer treatment regime with temozolomide
EP1251866A1 (de) *	2000-01-24	2002-10-30	Schering Corporation	Kombination von temozolomide und pegyliertem alpha-interferon zur behandlung von krebs
EP1908477A3 (de) *	2000-01-24	2008-06-11	Schering Corporation	Kombination aus Temozolomid und pegyliertem Interferon-alpha zur Krebsbehandlung
JP5208733B2 (ja)	2005-06-29	2013-06-12	イエダリサーチアンドデベロップメントカンパニーリミテッド	組換えインターフェロンα２（ＩＦＮα２）変異体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5017371A (en) *	1988-01-06	1991-05-21	Amarillo Cell Culture Company, Incorporated	Method for reducing side effects of cancer therapy
MY107071A (en) *	1988-12-01	1995-09-30	Schering Corp	Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
AU651998B2 (en) *	1990-10-12	1994-08-11	F. Hoffmann-La Roche Ag	Use of a retinoid
DE4244548C2 (de) *	1992-12-30	1997-10-02	Stockhausen Chem Fab Gmbh	Pulverförmige, unter Belastung wäßrige Flüssigkeiten sowie Blut absorbierende Polymere, Verfahren zu ihrer Herstellung und ihre Verwendung in textilen Konstruktionen für die Körperhygiene

1996
- 1996-10-01 ES ES96935971T patent/ES2183977T3/es not_active Expired - Lifetime
- 1996-10-01 AU AU73731/96A patent/AU719074B2/en not_active Ceased
- 1996-10-01 AT AT96935971T patent/ATE229343T1/de active
- 1996-10-01 EP EP96935971A patent/EP0859630B1/de not_active Expired - Lifetime
- 1996-10-01 DK DK96935971T patent/DK0859630T3/da active
- 1996-10-01 CA CA002233544A patent/CA2233544A1/en not_active Abandoned
- 1996-10-01 JP JP51432197A patent/JP4156028B2/ja not_active Expired - Fee Related
- 1996-10-01 DE DE69625373T patent/DE69625373T2/de not_active Expired - Lifetime
- 1996-10-01 PT PT96935971T patent/PT859630E/pt unknown
- 1996-10-01 WO PCT/US1996/015413 patent/WO1997012630A1/en not_active Ceased
2007
- 2007-03-26 JP JP2007080381A patent/JP2007169300A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JP4156028B2 (ja)	2008-09-24
EP0859630B1 (de)	2002-12-11
AU7373196A (en)	1997-04-28
DE69625373T2 (de)	2003-05-15
AU719074B2 (en)	2000-05-04
CA2233544A1 (en)	1997-04-10
ATE229343T1 (de)	2002-12-15
JPH11514995A (ja)	1999-12-21
WO1997012630A1 (en)	1997-04-10
ES2183977T3 (es)	2003-04-01
PT859630E (pt)	2003-02-28
DE69625373D1 (de)	2003-01-23
JP2007169300A (ja)	2007-07-05
EP0859630A1 (de)	1998-08-26

Similar Documents

Publication	Publication Date	Title
KR950701350A (ko)	1995-03-23	부작용 감소와 동시에 인터페론을 이용한 질환의 치료방법 및 조성물(methods and compositions for the treatment of diseases with interferon while reducing side effects)
DK0880350T3 (da)	2002-03-25	Behandling af dissemineret sklerose
DK0502092T3 (da)	1995-12-27	Oralt præparat til behandling af inflammatoriske tarmsygdomme
NO975309L (no)	1997-11-19	Anvendelse av rivavirin og alfa-interferon til behandling av hepatitt C
IL134345A0 (en)	2001-04-30	Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
DK254887D0 (da)	1987-05-19	Salve til behandling af hudsygdomme
DE69426334D1 (de)	2000-12-28	Parenterales Busulfan zur Behandlung von malignen Krankheiten
ATE247709T1 (de)	2003-09-15	3'utr des menschliches prohibitin-gens
NO931413D0 (no)	1993-04-16	Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
DK0858341T3 (da)	2001-11-19	Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin
PT859630E (pt)	2003-02-28	Combinacao de temozolomida e alfa-ifn no tratamento de cancro avancado
FI954127L (fi)	1995-09-04	Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa
ATE149840T1 (de)	1997-03-15	Behandlung von leberkrebs
KR950700737A (ko)	1995-02-20	기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
TR199801801T2 (xx)	1998-12-21	Madde k�t�ye kullan�m�n�n tedavisi.
DK0869813T3 (da)	2006-01-02	Anvendelse af beta-interferoner til behandling af restenose
UA10928C2 (uk)	1996-12-25	Спосіб профілактики гіперхолестериhемії
DK1150981T3 (da)	2003-07-21	Terapeutisk necleosidforbindelse
IT9021051A0 (it)	1990-07-25	"procedimento di estrzione e purificazione del gamma interferone umano ricombite"
MX9603833A (es)	1998-01-31	Tratamiento mejorado del cancer con temozolomida.
SE9003140D0 (sv)	1990-10-02	Method and composition for treatment of heart diseases
GEP19991514B (en)	1999-03-05	Method for Treatment with Interferon
EP1908477A3 (de)	2008-06-11	Kombination aus Temozolomid und pegyliertem Interferon-alpha zur Krebsbehandlung